# K123724: Dermiseb Cream

- Pathway: 510(k) (Traditional)
- Applicant: Igi Laboratories, Inc.
- Decided: Aug 28, 2013 after 267 days
- Product code: FRO (Dressing, Wound, Drug)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K961758 (1996). 4 ancestors in all.
4 later devices descend from it; 1 cites it directly.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K050158: Sinclair Seborrhea Emulsion, Sinclair Pharmaceuticals, Ltd. (2006) Summary page 1.

## Most influential descendants
- K152945: Alevicyn SG Antipruritic Gel (2015), 3 descendants of its own
- K171935: Alevicyn SG Antimicrobial Gel (2017), 1 descendant of its own
- K173896: Microcyn Antimicrobial Hydrogel (2018), 0 descendants of its own
- K162217: LOYON (2017), 0 descendants of its own

## Indications for use
Under the supervision of a healthcare professional, Dermiseb Cream is indicated to manage and relieve the signs and symptoms of seborrhea and seborrheic dermatitis such as itching, erythema, scaling and pain. Dermiseb Cream also aids to relieve dry, waxy skin by maintaining a moist wound and skin environment. A moist wound and skin environment is beneficial to the healing process. Dermiseb Cream is indicated for use in: * Seborrhea * Seborrheic Dermatitis

Source page: https://510kreport.com/device/K123724
Methodology: https://510kreport.com/methodology